“Experimental evidence suggests the endogenous cannabinoid system may protect against colonic inflammation, leading to the possibility that activation of this system may have a therapeutic role in inflammatory bowel disease (IBD).
Medicinal use of cannabis for chronic pain and other symptoms has been reported in a number of medical conditions.
We aimed to evaluate cannabis use in patients with IBD…
Cannabis use is common amongst patients with IBD for symptom relief, particularly amongst those with a history of abdominal surgery, chronic abdominal pain and/or a low quality of life index.
The therapeutic benefits of cannabinoid derivatives in IBD may warrant further exploration.”